Available
CoA · 99.7%
Loading
New pricing now live20-vial packs from $20 a vialFree shipping over $200Canada Post tracked deliveryCertificate of Analysis on requestCanadian owned, operated & sourced
Loading
C221H366N72O67SResearch Material
A growth-hormone-releasing factor analogue listed as a reference material for in-vitro and analytical research applications. Molecular reference information is provided below.
Batch documentation
Available on request
Canada-wide shipping
Tracked delivery
Lyophilized
Cold-chain handling
No payment is taken now — pay by Interac e-transfer or Wise after checkout.
Documentation
A Certificate of Analysis for this material is not published yet. Ask us for its current documentation status before ordering.
Request documentationFor laboratory research use only. Not for human or veterinary use. No dosing or administration guidance is provided.
In the research literature, tesamorelin is described as a synthetic analogue of growth-hormone-releasing hormone (GHRH). It is studied in models examining GHRH-receptor binding and downstream somatotroph signalling, which is why it appears as a reference tool in growth-factor and endocrine-axis research. Supplied for laboratory research only; no therapeutic, efficacy, or human/veterinary-use claims are made.
Provided for research context only. This material is supplied for laboratory, analytical, and research use exclusively — not for human or veterinary use. No therapeutic, diagnostic, dosing, or efficacy claims are made or implied.
A growth-hormone-releasing factor analogue listed as a reference material for in-vitro and analytical research applications. Molecular reference information is provided below.
Tesamorelin 20 mg is listed within the growth-factor research category as a research reference material. This entry provides general and molecular reference information. Batch-specific documentation is published only when verified records are available for a listed material.
No reviews yet. Be the first to review Tesamorelin 20 mg.
